Neuralink, the neurotechnology company of Tesla CEO Elon Musk, plans to begin human clinical trials of its wireless brain computing chips within an estimated six months. “We’re extremely careful and want to make sure it’s working properly before we put a device into a human being, but we’ve submitted, I believe, most of our paperwork to the FDA,” Musk said during a presentation of the implant. .
Musk wants to use the interfaces to cure neurological diseases such as Alzheimer’s, dementia and spinal cord injuries. The Austin, Texas-based company has successfully conducted clinical studies in animals in recent years, krone.at reported.
At Neuralink’s last public presentation, more than a year ago, a monkey with a brain chip controlled a computer game using only its mind.
However, Neuralink is behind schedule. Musk said in 2019 that he was aiming for regulatory approval by the end of 2020. At a conference in late 2021, he then said he hoped to begin human trials later this year.
Source: Krone
I am an experienced and passionate journalist with a strong track record in news website reporting. I specialize in technology coverage, breaking stories on the latest developments and trends from around the world. Working for Today Times Live has given me the opportunity to write thought-provoking pieces that have caught the attention of many readers.
